Free Trial
NASDAQ:MLAB

Mesa Laboratories Q4 2024 Earnings Report

Mesa Laboratories logo
$112.01 -0.91 (-0.81%)
Closing price 04/17/2025 04:00 PM Eastern
Extended Trading
$112.12 +0.10 (+0.09%)
As of 04/17/2025 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Mesa Laboratories EPS Results

Actual EPS
$2.25
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Mesa Laboratories Revenue Results

Actual Revenue
$58.90 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Mesa Laboratories Announcement Details

Quarter
Q4 2024
Time
N/A
Conference Call Date
Wednesday, June 5, 2024
Conference Call Time
2:00AM ET

Upcoming Earnings

Mesa Laboratories' Q4 2025 earnings is scheduled for Wednesday, June 4, 2025, with a conference call scheduled on Friday, May 30, 2025 at 8:00 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Mesa Laboratories Earnings Headlines

MESA LABS DECLARES QUARTERLY DIVIDEND
Mesa Laboratories: Green Shoots Emerge
[Action Required] Claim Your FREE IRS Loophole Guide
This shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the biggest "dollar reset" since 1971.
What Makes Mesa Laboratories (MLAB) a Valuable Stock?
Wells Fargo Sticks to Their Sell Rating for Mesa Laboratories (MLAB)
See More Mesa Laboratories Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Mesa Laboratories? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Mesa Laboratories and other key companies, straight to your email.

About Mesa Laboratories

Mesa Laboratories (NASDAQ:MLAB) develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the dental and pharmaceutical industries. The Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for inherited genetic disease testing, pharmacogenetics, oncology testing, infectious disease testing, doping and toxicology testing, and other differentiated applications for use in research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; PurePep Chorus and Symphony instruments for peptide synthesis; and PurePep EasyClean products for purifying peptides. The Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing, laboratory, and hospital environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems, offered under DialyGuard, ViewPoint, DataTrace, DryCal, and BGI brands. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.

View Mesa Laboratories Profile

More Earnings Resources from MarketBeat